pentobarbital decreases levels of elvitegravir/cobicistat/emtricitabine/tenofovir DF by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. May perhaps lead to loss of virologic response and feasible resistance. Pentobarbital belongs to your barbiturate course of medications a